It is time to have better oversite and accountability in performing many not indicated percutaneous coronary interventions in patients with chronic total occlusions

With the introduction of percutaneous coronary intervention (PCI) by Dr. Gruntzig [1], treatment of coronary disease underwent revolution and led to PCI being one of most commonly performed procedures in the world. Since the first PCI, many decades had passed with numerous clinical trials that are available to address various clinical scenarios. It is now clear that real mortality benefit of PCI occurs mostly in the treatment of patients with acute coronary syndrome [2]. PCI performed in the setting of stable coronary disease has rarely shown any mortality benefit even in the case of proven ischemia [3,4].
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research